Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 3 de 3
Filtrer
Plus de filtres










Base de données
Gamme d'année
1.
Pain Manag Nurs ; 25(3): 265-284, 2024 Jun.
Article de Anglais | MEDLINE | ID: mdl-38462401

RÉSUMÉ

BACKGROUND: Although there is a body of literature on the implementation of interventions to manage procedural pain and anxiety in youth with autism spectrum disorders (ASD), we found no literature presenting the current state of knowledge on this topic. OBJECTIVES: To review the state of knowledge on interventions for the management of procedural pain and anxiety in children and adolescents with ASD. METHOD: A scoping review using PRISMA-ScR was conducted. DATA SOURCES: PubMed, MEDLINE, all EBM reviews, Embase, APA PsychInfo, EBSCO CINAHL, and ProQuest Dissertations and Theses Global databases were searched. Gray literature was also searched. ANALYSIS METHOD: Braun and Clarke's (2006) model for thematic analysis in psychology was used to synthesize the search results. RESULTS: Thirty articles were selected. Analysis of the extracted data revealed four elements of intervention for better management of procedural pain and anxiety in the study population: 1) characteristics of the procedure and the immediate environment; 2) parent-child interactions; 3) health care provider-child interactions; and 4) direct pharmacological and nonpharmacological interventions. IMPLICATIONS FOR NURSING PRACTICE: Nurses must be able to implement appropriate interventions for the management of procedural pain and anxiety in youth with an autism spectrum disorder.


Sujet(s)
Anxiété , Trouble du spectre autistique , Gestion de la douleur , Humains , Trouble du spectre autistique/complications , Trouble du spectre autistique/psychologie , Trouble du spectre autistique/soins infirmiers , Trouble du spectre autistique/thérapie , Adolescent , Enfant , Anxiété/psychologie , Anxiété/étiologie , Anxiété/thérapie , Gestion de la douleur/méthodes , Gestion de la douleur/normes , Douleur liée aux interventions/psychologie , Douleur liée aux interventions/étiologie
2.
Environ Monit Assess ; 179(1-4): 163-75, 2011 Aug.
Article de Anglais | MEDLINE | ID: mdl-20890786

RÉSUMÉ

Starting in 2006, a monitoring of Giardia lamblia and Cryptosporidium parvum occurrence was conducted for 2 years in the largest drinking water reservoir of Luxembourg (Esch-sur-Sûre reservoir) using microscopy and qPCR techniques. Parasite analyses were performed on water samples collected from three sites: site A located at the inlet of the reservoir, site B located 18 km downstream site A, at the inlet of the drinking water treatment plant near the dam of the reservoir and site C where the finished drinking water is injected in the distribution network. Results show that both parasites are present in the reservoir throughout the year with a higher occurrence of G. lamblia cysts compared to C. parvum oocysts. According to our results, only 25% of the samples positive by microscopy were confirmed by qPCR. (Oo)cyst concentrations were 10 to 100 times higher at site A compared to site B and they were positively correlated to the water turbidity and negatively correlated to the temperature. Highest (oo)cyst concentrations were observed in winter. In contrast, no relationship between the concentrations of (oo)cysts in the reservoir and rain events could be established. Though a correlation has been observed between both parasites and faecal indicators in the reservoir, some discrepancies highlight that the latter do not represent a reliable tool to predict the presence/absence of these pathogenic protozoa. In summer 2007, the maximal risk of parasite infection per exposure event for swimmers in the reservoir was estimated to be 0.0015% for C. parvum and 0.56% for G. lamblia. Finally, no (oo)cysts could be detected in large volumes of finished drinking water.


Sujet(s)
Cryptosporidium parvum/croissance et développement , Surveillance de l'environnement/méthodes , Eau douce/parasitologie , Giardia lamblia/croissance et développement , Alimentation en eau/analyse , Cryptosporidium parvum/génétique , Cryptosporidium parvum/isolement et purification , Giardia lamblia/génétique , Giardia lamblia/isolement et purification , Microscopie de fluorescence , Oocystes , Appréciation des risques , Pollution de l'eau/analyse , Pollution de l'eau/statistiques et données numériques , Alimentation en eau/statistiques et données numériques
3.
Curr Microbiol ; 46(3): 157-62, 2003 Mar.
Article de Anglais | MEDLINE | ID: mdl-12567236

RÉSUMÉ

Two strains of the spoiling bacterium S. putrefaciens showed an adaptation capacity to hyperosmotic shock when they were pretreated with a sublethal concentration of NaCl. The maximal tolerance factor for the CIP 69.29 strain was obtained when cells were incubated for 1 h in the presence of 1.5% NaCl, whereas for the J13.1 strain, an incubation of 15 min in the presence of 1% NaCl seemed to be the optimal conditions to harden the cells against a subsequent lethal salt treatment. During NaCl adaptation and growth at low temperatures (2 degrees C), 37 and 32 polypeptides were induced respectively. Interestingly, 11 proteins were common between the two different stress responses. These proteins and the corresponding genes seem to play a key role in the observed cross-protection towards the NaCl challenge induced by growth of the cultures at 2 degrees C. One of the overlapping proteins has been identified to correspond to the alkyl hydroperoxide reductase (AhpC) of S. putrefaciens. Northern blot analysis showed that induction of this enzyme was accompanied by accumulation of the corresponding transcript under both conditions.


Sujet(s)
Acclimatation , Basse température , Shewanella putrefaciens/croissance et développement , Chlorure de sodium/pharmacologie , Séquence d'acides aminés , Protéines bactériennes/analyse , Protéines bactériennes/biosynthèse , Électrophorèse bidimensionnelle sur gel/méthodes , Données de séquences moléculaires , Pression osmotique , Peroxidases/analyse , Peroxirédoxines , Alignement de séquences , Shewanella putrefaciens/effets des médicaments et des substances chimiques , Shewanella putrefaciens/métabolisme , Shewanella putrefaciens/physiologie
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE